Clinical Study Results
How many participants had adverse reactions?
There were 25% of participants who reported adverse reactions during this study. This
was 11 out of 44 participants.
None of the participants stopped taking the study drug because of adverse reactions.
What adverse reactions did the participants have?
The most common adverse reactions were headache and nausea. The adverse reactions
in the table below happened in at least 2 of the total participants. There were other
adverse reactions, but these happened in fewer participants.
Adverse reactions that happened during this study
Ticagrelor
Powdered Ticagrelor as several
ticagrelor as several children’s Approved
mixed with children’s tablets mixed tablets of
a liquid tablets with water ticagrelor
(Out of 43 (Out of 41 (Out of 43 (Out of 42
participants) participants) participants) participants)
Headache 7.0% (3) 4.9% (2) 7.0% (3) 7.1% (3)
Nausea 0.0% (0) 0.0% (0) 4.7% (2) 2.4% (1)
How has this study helped patients and
researchers?
This study helped researchers learn how much ticagrelor got into the blood when taken
in different forms by healthy participants. It also helped researchers learn what adverse
reactions the healthy participants had while taking the different forms.
Researchers look at the results of many studies to decide which treatments work best and
are safest. This summary shows only the main results from this 1 study. Other studies may
provide new information or different results.
Further clinical studies with ticagrelor are planned.
7